학술논문
Phase I/II study of bi-weekly XELIRI plus bevacizumab treatment in patients with metastatic colorectal cancer resistant to oxaliplatin-based first-line chemotherapy.
Document Type
Journal Article
Author
Source
Subject
*BEVACIZUMAB
*COLON cancer treatment
*OXALIPLATIN
*CANCER chemotherapy
*PROGRESSION-free survival
*THERAPEUTICS
*ANTINEOPLASTIC agents
*CAMPTOTHECIN
*CLINICAL trials
*COLON tumors
*COMPARATIVE studies
*DRUG resistance in cancer cells
*DOSE-effect relationship in pharmacology
*RESEARCH methodology
*MEDICAL cooperation
*METASTASIS
*ORGANOPLATINUM compounds
*PROGNOSIS
*RESEARCH
*SURVIVAL
*EVALUATION research
*TREATMENT effectiveness
RECTUM tumors
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
0344-5704
Abstract